Company CVAbout Wockhardt Ltd 
Wockhardt Ltd
Mid Cap
Pharmaceuticals & Drugs
Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out.
Company Coordinates
Company Details
D-4 MIDC, Chikalthana Aurangabad. Maharashtra : 431006
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 76.70 Cr
Number of Shares
15.34 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
26-Aug-2024
15.34
76.70
8610
5
Issued under ESOP Scheme
26-Mar-2024
15.34
76.70
9285163
5
Qualified Institutional Placement
19-Jan-2024
14.41
72.06
14300
5
Issued under ESOP Scheme
25-Oct-2023
14.41
72.05
6900
5
Issued under ESOP Scheme
05-May-2023
14.41
72.05
6250
5
Issued under ESOP Scheme
06-Feb-2023
14.41
72.04
28170
5
Issued under ESOP Scheme
08-Mar-2022
14.41
72.03
33244650
5
Right Issues
18-Oct-2021
11.08
55.41
10750
5
Issued under ESOP Scheme
17-Aug-2021
11.08
55.40
23600
5
Issued under ESOP Scheme
09-Mar-2021
11.08
55.39
4200
5
Issued under ESOP Scheme
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
16.9835
Mutual Funds
Held by 15 Schemes (7.13%)
FIIs
Held by 114 FIIs (6.54%)
Promoter with highest holding
Themisto Trustee Company Private Limited (40.16%)
Highest Public shareholder
Estate Of Late Mr. Rakesh Jhunjhunwala (1.75%)
Individual Investors Holdings
27.49%
Board of Directors
Management
Designation
Remuneration
H F Khorakiwala
Executive Chairman
2.4 cr
Aman Mehta
Independent Director
16.0 lacs
Murtaza H Khorakiwala
Managing Director
2.4 cr
Huzaifa H Khorakiwala
Executive Director
2.4 cr
Sanjaya Baru
Independent Director
16.0 lacs
D S Brar
Independent Director
17.0 lacs
Tasneem Mehta
Independent Director
16.0 lacs
Vinesh Kumar Jairath
Independent Director
16.0 lacs
Zahabiya Khorakiwala
Non-Exec & Non-Independent Dir
4.0 lacs
Akhilesh Gupta
Independent Director
16.0 lacs
Amelia Fernandes
Independent Director
0
Rashmi Mamtura
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Finished Goods Purchases
85.2
0%
Finished Goods Purchases
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals
2,015.67
93.75%
Sale of Services
73.95
3.44%
Sale of Intellectual Property
38.95
1.81%
Pharmaceuticals
Pharmaceuticals
Sale of Services
Sale of Services
Sale of Intellectual Property
Sale of Intellectual Property
Stock DNARevenue and Profits:
Net Sales:
721 Cr
(Quarterly Results - Dec 2024)
Net Profit:
14 Cr
Pharmaceuticals & Drugs
INR 21,439 Cr (Mid Cap)
NA (Loss Making)
33
0.00%
0.62
-8.48%
5.74
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
